Panacea Biotec Limited — Important, 07-07-2025: Updates

Panacea Biotec has announced a minor insider trading violation by the immediate relative of a General Manager, involving 155 shares with no profit made. A penalty of Rs. 750 was imposed and paid to SEBI’s Investor Protection Fund. The company emphasized strict future compliance with its Code of Conduct. This follows a previous similar violation by the same relative during FY 2023-24, which was penalized accordingly. No operational or business impact is indicated from these events.